For the Inventor, By the Inventor

Enter assignee name

Princeton, NJ, United States of America

Bristol-Myers Squibb Pharma Corporation

USPTO Granted Patents = 10

Forward Citations = 65

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Richard Eric Olson (3 out of 108 patents)

Dean A Wacker (2 out of 50 patents)

Michael G Yang (2 out of 47 patents)

4. Douglas G Batt (1 out of 54 patents)

5. Haisheng Wang (1 out of 28 patents)

6. John V Duncia (1 out of 55 patents)

7. Jingwu Duan (1 out of 52 patents)

8. Gregory R Ott (1 out of 25 patents)

9. Daniel S Gardner (1 out of 36 patents)

10. Joseph B Santella (1 out of 50 patents)

11. Milind Rajopadhye (1 out of 43 patents)

12. Soo Sung Ko (1 out of 41 patents)

13. Xiao Tao Chen (1 out of 4 patents)

14. Robert J Chorvat (1 out of 48 patents)

15. Parthasarathi Rajagopalan (1 out of 13 patents)

10 patents: Sort by Forward Citations

1. 7456278 - Lactams substituted by cyclic succinates as inhibitors of Aβ protein production (2008-11-25),

2. 7390896 - Cyclic malonamides as inhibitors of Aβ protein production (2008-06-24),

3. 7390802 - Substituted lactams as inhibitors of Aβ protein production (2008-06-24),

4. 6969721 - Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors (2005-11-29),

5. 6818659 - (2S)-2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides (2004-11-16),

6. 6818648 - Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof (2004-11-16),

7. 6720329 - Spiro-cyclic &bgr;-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-&agr; converting enzyme (TACE) (2004-04-13),

8. 6627629 - N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity (2003-09-30),

9. 6608227 - Benzylcycloalkyl amines as modulators of chemokine receptor activity (2003-08-19),

10. 6555686 - Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors (2003-04-29),

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines to patients with serious diseases. With a mission to extend and enhance human life, they are dedicated to addressing some of the world's biggest healthcare challenges. The company's portfolio includes treatments for cancer, HIV, cardiovascular diseases, and more.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#74 in Princeton, NJ

#1,101 in New Jersey

#29,001 in US

#54,303 in the World

Princeton, NJ, United States of America

Bristol-Myers Squibb Pharma Corporation

Forward Citations = 65

31 inventors:

Richard Eric Olson (3 out of 108 patents)

Dean A Wacker (2 out of 50 patents)

Michael G Yang (2 out of 47 patents)

4. Douglas G Batt (1 out of 54 patents)

5. Haisheng Wang (1 out of 28 patents)

Please report any incorrect information to support@idiyas.com

Loading…